“3D Systems (NYSE:DDD) has announced that it is diving further into the bioprinting space, upon significant progress made by its partner United Therapeutics Corporation (NASDAQ:UTHR) and its subsidiary Lung Biotechnology PBC. Together, the companies have developed a method for quickly fabricating hydrogel scaffolds that are then perfused with living cells. The technology has shown such promising results for tissue engineering applications that 3D Systems has decided to invest much more into bioprinting…”

Read More: https://3dprint.com/278342/3d-printed-vascularized-lung-models-push-3d-systems-into-bioprinting/